Clinical Trial Update: Measurement of Patient Reported Outcomes in Renal Transplant Patients With and Without Gastrointestinal (GI) Symptoms (PROGIS) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating patient-reported outcomes in renal transplant patients with and without GI symptoms (PROGIS).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Maintenance Transplant

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Kidney Maintenance Transplant | Phase 4 | Status: COMPLETED